Position in JNJ
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$225,525
+$8,463 QoQ
Shares Held
888
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
17 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026EARNEST PARTNERS LLC holds $139,876,807 across 4 Drug Manufacturers - General names. JNJ ranks #3 (0.2% of the industry book) .
All Filings in JNJ
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $225,525 | 888 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $217,062 | 888 | Shares | Sole | 2026-05-15 | |
| 2023-09-30 | $193,441 | 1,242 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $205,575 | 1,242 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $192,510 | 1,242 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $219,399 | 1,242 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $202,893 | 1,242 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $220,467 | 1,242 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $220,119 | 1,242 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $212,468 | 1,242 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $200,583 | 1,242 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $204,607 | 1,242 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $204,122 | 1,242 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $195,465 | 1,242 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $184,908 | 1,242 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $178,881 | 1,272 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $166,797 | 1,272 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||